flynn	10.1093/neuonc/nou328	<http://dx.doi.org/10.1093/neuonc/nou328>; rel="canonical", <http://academic.oup.com/neuro-oncology/article-pdf/17/9/1261/17430352/nou328.pdf>; version="vor"; rel="item"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1093/neuonc/nou328"><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/patrick-j-flynn-59f9ti5guhf0"><j.3:name>Patrick J. Flynn</j.3:name><j.3:familyName>Flynn</j.3:familyName><j.3:givenName>Patrick J.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/paul-d-brown-59f9ti5guhf0"><j.3:name>Paul D. Brown</j.3:name><j.3:familyName>Brown</j.3:familyName><j.3:givenName>Paul D.</j.3:givenName></j.3:Person></j.0:creator><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2014-12-18</j.0:date><j.1:doi>10.1093/neuonc/nou328</j.1:doi><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/david-schiff-59f9ti5guhf0"><j.3:name>David Schiff</j.3:name><j.3:familyName>Schiff</j.3:familyName><j.3:givenName>David</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/steven-mcgraw-59f9ti5guhf0"><j.3:name>Steven McGraw</j.3:name><j.3:familyName>McGraw</j.3:familyName><j.3:givenName>Steven</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="doi:10.1093/neuonc/nou328"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/kurt-a-jaeckle-59f9ti5guhf0"><j.3:name>Kurt A. Jaeckle</j.3:name><j.3:familyName>Jaeckle</j.3:familyName><j.3:givenName>Kurt A.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/keith-l-ligon-59f9ti5guhf0"><j.3:name>Keith L. Ligon</j.3:name><j.3:familyName>Ligon</j.3:familyName><j.3:givenName>Keith L.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/caterina-giannini-59f9ti5guhf0"><j.3:name>Caterina Giannini</j.3:name><j.3:familyName>Giannini</j.3:familyName><j.3:givenName>Caterina</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/daniel-j-ma-59f9ti5guhf0"><j.3:name>Daniel J. Ma</j.3:name><j.3:familyName>Ma</j.3:familyName><j.3:givenName>Daniel J.</j.3:givenName></j.3:Person></j.0:creator><j.0:identifier>10.1093/neuonc/nou328</j.0:identifier><j.2:doi>10.1093/neuonc/nou328</j.2:doi><j.1:endingPage>1269</j.1:endingPage><j.1:startingPage>1261</j.1:startingPage><j.0:publisher>Oxford University Press (OUP)</j.0:publisher><j.0:title>A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K</j.0:title><owl:sameAs rdf:resource="info:doi/10.1093/neuonc/nou328"/><j.2:volume>17</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/joon-h-uhm-59f9ti5guhf0"><j.3:name>Joon H. Uhm</j.3:name><j.3:familyName>Uhm</j.3:familyName><j.3:givenName>Joon H.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jann-n-sarkaria-59f9ti5guhf0"><j.3:name>Jann N. Sarkaria</j.3:name><j.3:familyName>Sarkaria</j.3:familyName><j.3:givenName>Jann N.</j.3:givenName></j.3:Person></j.0:creator><j.2:pageEnd>1269</j.2:pageEnd><j.2:pageStart>1261</j.2:pageStart><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/jan-c-buckner-59f9ti5guhf0"><j.3:name>Jan C. Buckner</j.3:name><j.3:familyName>Buckner</j.3:familyName><j.3:givenName>Jan C.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/timothy-j-kaufmann-59f9ti5guhf0"><j.3:name>Timothy J. Kaufmann</j.3:name><j.3:familyName>Kaufmann</j.3:familyName><j.3:givenName>Timothy J.</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/1523-5866"><owl:sameAs>urn:issn:1523-5866</owl:sameAs><j.1:issn>1522-8517</j.1:issn><j.2:issn>1522-8517</j.2:issn><owl:sameAs>urn:issn:1522-8517</owl:sameAs><j.0:title>Neuro-Oncology</j.0:title><j.1:issn>1523-5866</j.1:issn><j.2:issn>1523-5866</j.2:issn></j.2:Journal></j.0:isPartOf><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/s-keith-anderson-59f9ti5guhf0"><j.3:name>S. Keith Anderson</j.3:name><j.3:familyName>Anderson</j.3:familyName><j.3:givenName>S. Keith</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/evanthia-galanis-59f9ti5guhf0"><j.3:name>Evanthia Galanis</j.3:name><j.3:familyName>Galanis</j.3:familyName><j.3:givenName>Evanthia</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>17</j.1:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/patrick-j-peller-59f9ti5guhf0"><j.3:name>Patrick J. Peller</j.3:name><j.3:familyName>Peller</j.3:familyName><j.3:givenName>Patrick J.</j.3:givenName></j.3:Person></j.0:creator></rdf:Description></rdf:RDF>
